Cocaine

SciSparc Announces Additional Positive Results from Part 3 of Clearmind Medicine Inc. Preclinical Study for the Treatment of Cocaine Addiction

SciSparc Announces Additional Positive Results from Part 3 of Clearmind Medicine Inc. Preclinical Study for the Treatment of Cocaine Addiction

Results from preclinical in vivo research studies suggest that Clearmind’s MEAI drug candidate may be effective in treating addiction without disrupting the natural reward process. TEL AVIV, Israel, Jan. 17, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a clinical-stage specialty pharmaceutical company focused on developing therapies to treat central nervous system …

SciSparc Announces Additional Positive Results from Part 3 of Clearmind Medicine Inc. Preclinical Study for the Treatment of Cocaine Addiction Read More »

Taiwan Center Notes: Taiwan, Cocaine and Drug Production - Taipei Times

Taiwan Center Notes: Taiwan, Cocaine and Drug Production – Taipei Times

Japan used Taiwan as a base to grow a variety of tropical herbal medicines that were indispensable in the early days of the pharmaceutical industry, which helped expand its empire. By Michael Turton / Contributing Journalist After Taiwan became a Japanese colony in 1895, the government of Japan, always interested in proposals to increase its …

Taiwan Center Notes: Taiwan, Cocaine and Drug Production – Taipei Times Read More »